美國舒適系統 FIX 深 滬
等待開盤 07-18 09:30:00 美东时间
552.20
+5.570
+1.02%
華盛通- 最 高555.105
- 今 開549.57
- 成交量 13.72万股
- 最 低 544.44
- 昨 收 546.63
- 總市值 194.79亿
- 52周最高 555.105
- 市盈率 靜 37.81
- 換手率 0.39%
- 52周最低 271.425
- 委 比 -91.39%
- 總股本 3527.48万
- 歷史最高 555.105
- 量 比 0.92
- 振 幅 1.95%
- 歷史最低 1.635
- 每 手 1
- 風險率 70.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Price Over Earnings Overview: Comfort Systems USA
In the current session, the stock is trading at $547.25, after a 0.79% spike. O...
07-16 00:00
QFII业务首单落地！金证与世纪证券携手再筑里程碑
2025年6月， 世纪证券QFII业务实现里程碑式突破！ 6月9日，托管人结算模式下的世纪证券迎来首位QFII客户成功交易；6月24日，券商结算模式下的世纪证券...
07-11 11:31
Shares of housing-related stocks are trading higher following a decline in MBA 30-year mortgage rates data, along with an increase in MBA Mortgage Applications data and Mortgage Refinance Index data. This may indicate that more buyers may enter the housing market.
Shares of housing-related stocks are trading higher following a decline in MBA ...
07-10 03:54
中国跑山鞋市场崛起：十大国产品牌竞速山野，探野者以东方美学破局
（转自：辰珵） 随着国内越野跑赛事规模突破500万人次，中国正成为全球跑山鞋技术创新的核心战场。根据《2025中国户外产业白皮书》及天猫、京东等平台数据，以下...
07-05 10:01
站在降息的十字路口——2025年下半年美债市场展望
（转自：浙商银行FICC） 作者｜郑宁 马思敏 01 2025年上半年回顾 2025年上半年美债市场交易主题反复横跳，节奏变化快，波动之剧烈...
07-02 07:00
美股大行评级 | 巨大分歧！Circle获多家大行首予评级目标价在80~250之间；Stifel上调甲骨文评级至"买入"，目标价升至250美元
美股大行评级 | 巨大分歧！Circle获多家大行首予评级目标价在80~250之间；Stifel上调甲骨文评级至"买入"，目标价升至250美元
07-01 09:24
DA Davidson Maintains Buy on Comfort Systems USA, Raises Price Target to $630
DA Davidson analyst Brent Thielman maintains Comfort Systems USA (NYSE:FIX) with a Buy and raises the price target from $465 to $630.
06-30 22:47
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers during the week and a look at the past and future catalysts.
06-28 21:11
How Do Investors Really Feel About Comfort Systems USA?
Comfort Systems USA's (NYSE:FIX) short percent of float has risen 13.16% since ...
06-28 01:00
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data
Pfizer's Hympavzi showed superior bleed control in hemophilia A and B patients with inhibitors, reducing bleeding rates and showing good tolerability.
06-27 01:47
